A high-affinity, tryptophan-selective amino acid transport system in human macrophages

Journal of Leukocyte Biology

Volumn 80, Issue 6, 2006, Pages 1320-1327

  Seymour, Robert L ^a   Ganapathy, Vadivel ^a   Mellor, Andrew L ^a   Munn, David H ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Antigen presenting cells; Indoleamine 2,3 dioxygenase; Tolerance

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; TRYPTOPHAN;

AMINO ACID TRANSPORT; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MACROPHAGE; MEMBRANE TRANSPORT; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

AMINO ACID TRANSPORT SYSTEM L; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; COCULTURE TECHNIQUES; FEMALE; FETUS; HUMANS; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MACROPHAGES; MICE; PREGNANCY; T-LYMPHOCYTES; TRYPTOPHAN;

MURINAE;

EID: 33845402200     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1205727     Document Type: Article

References (42)

1. Shimizu, T., Nomiyama, S., Hirata, F., Hayaishi, O. (1978) Indoleamine 2,3-dioxygenase. J. Biol. Chem. 253, 4700-4706.
2. Dai, W., Gupta, S. L. (1990) Molecular cloning, sequencing and expression of human interferon-γ-inducible indoleamine 2,3-dioxygenase cDNA. Biochem. Biophys. Res. Commun. 168, 1-8.
3. Taylor, M. W., Feng, G. (1991) Relationship between interferon-γ, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 5, 2516-2522.
4. Suzuki, T., Yuasa, H., Imai, K. (1996) Convergent evolution. The gene structure of Sulculus 41 kDa myoglobin is homologous with that of human indoleamine dioxygenase. Biochim. Biophys. Acta 1308, 41-48.
5. Gupta, S. L., Carlin, J. M., Pyati, P., Dai, W., Pfefferkorn, E. R., Murphy, M. J. (1994) Antiparasitic and antiproliferative effects of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts. Infect. Immun. 62, 2277-2284.
6. Thomas, S. M., Garrity, L. F., Brandt, C. R., Schobert, C. S., Feng, G-S., Taylor, M. W., Carlin, J. M., Byrne, G. I. (1993) IFN-γ-mediated antimicrobial response: indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or Toxoplama growth. J. Immunol. 150, 5529-5534.
7. Pfefferkorn, E. R. (1984) Interferon γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. USA 81, 908-912.
8. Bodaghi, B., Goureau, O., Zipeto, D., Laurent, L., Virelizier, J. L., Michelson, S. (1999) Role of IFN-γ-induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells. J. Immunol. 162, 957-964.
9. Mellor, A. L., Munn, D. H. (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4, 762-774.
10. Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., Mellor, A. L. (1998) Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281, 1191-1193.
11. Mellor, A. L., Sivakumar, J., Chandler, P., Smith, K., Molina, H., Mao, D., Munn, D. H. (2001) Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat. Immunol. 2, 64-68.
12. Grohmann, U., Fallarino, F., Bianchi, R., Orabona, C., Vacca, C., Fioretti, M. C., Puccetti, P. (2003) A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J. Exp. Med. 198, 153-160.
13. Gurtner, G. J., Newberry, R. D., Schloemann, S. R., McDonald, K. G., Stenson, W. F. (2003) Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice. Gastroenterology 125, 1762-1773.
14. Mellor, A. L., Baban, B., Chandler, P. R., Manlapat, A., Kahler, D. J., Munn, D. H. (2005) Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN type 1 signaling. J. Immunol. 175, 5601-5605.
15. Munn, D. H., Sharma, M. D., Baban, B., Harding, H. P., Zhang, Y., Ron, D., Mellor, A. L. (2005) GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22, 633-642.
16. Uyttenhove, C., Pilotte, L., Theate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., Van Den Eynde, B. J. (2003) Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat. Med. 9, 1269-1274.
17. Munn, D. H., Sharma, M. D., Hou, D., Baban, B., Lee, J. R., Antonia, S. J., Messina, J. L., Chandler, P., Koni, P. A., Mellor, A. (2004) Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J. Clin. Invest. 114, 280-290.
18. Muller, A. J., Duhadaway, J. B., Donover, P. S., Sutanto-Ward, E., Prendergast, G. C. (2005) Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat. Med. 11, 312-319.
19. Mellor, A. L., Keskin, D. B., Johnson, T., Chandler, P., Munn, D. H. (2002) Cells expressing indoleamine 2,3 dioxygenase inhibit T cell responses. J. Immunol. 168, 3771-3776.
20. Alexander, A. M., Crawford, M., Bertera, S., Rudert, W. A., Takikawa, O., Robbins, P. D., Trucco, M. (2002) Indoleamine 2,3-dioxygenase expression in transplanted NOD islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. Diabetes 51, 356-365.
21. Swanson, K. A., Zheng, Y., Heidler, K. M., Mizobuchi, T., Wilkes, D. S. (2004) CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase. Am. J. Respir. Cell Mol. Biol. 30, 311-318.
22. Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., Mellor, A. L. (1999) Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189, 1363-1372.
23. Hwu, P., Du, M. X., Lapointe, R., Do, M., Taylor, M. W., Young, H. A. (2000) Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J. Immunol. 164, 3596-3599.
24. Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., Slingluff, C. L., Mellor, A. L. (2002) Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297, 1867-1870.
25. Munn, D. H., Sharma, M. D., Mellor, A. L. (2004) Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J. Immunol. 172, 4100-4110.
26. Kudo, Y., Boyd, C. A. (2001) The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants. J. Physiol. 531, 417-423.
27. Ganapathy, V., Inoue, K., Prasad, P. D., Ganapathy, M. E. (2004) Cellular uptake of amino acids: systems and regulation. In Metabolic and Therapeutic Aspects of Amino Acids in Clinical Nutrition , 2nd ed. (L. A. Cynober, ed.), Boca Raton, FL, CRC, 63-78.
28. Palacin, M., Estevez, R., Bertran, J., Zorzano, A. (1998) Molecular biology of mammalian plasma membrane amino acid transporters. Physiol. Rev. 78, 969-1054.
29. Munn, D. H., Armstrong, E. (1993) Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by interferon-γ. Cancer Res. 53, 2603-2613.
30. Deves, R., Boyd, C. A. R. (1998) Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol. Rev. 78, 487-545.
31. Cheng, Y., Prusoff, W. H. (1973) Relationship between the inhibtion constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
32. Ganapathy, M. E., Leibach, F. H., Mahesh, V. B., Howard, J. C., Devoe, L. D., Ganapathy, V. (1986) Characterization of tryptophan transport in human placental brush border membrane vesicles. Biochem. J. 238, 201-208.
33. + amino acid transport activity in cultured vascular smooth muscle cells. J. Cell. Physiol. 156, 626-634.
34. Prasad, P. D., Leibach, F. H., Mahesh, V. B., Ganapathy, V. (1994) Relationship between thyroid hormone transport and neutral amino acid transport in JAR human choriocarcinoma cells. Endocrinology 134, 574-581.
35. +-independent neutral amino acid transporter with broad substrate selectivity. J. Biol. Chem. 274, 19745-19751.
36. Prasad, P. D., Wang, H., Huang, W., Kekuda, R., Rajan, D. P., Leibach, F. H., Ganapathy, V. (1999) Human LAT1, a subunit for system L amino acid transporter: molecular cloning and transport function. Biochem. Biophys. Res. Commun. 255, 283-288.
37. Verrey, F. (2003) System L: heteromeric exchangers of large, neutral amino acids involved in directional transport. Pflugers Arch. 445, 529-533.
38. Burke, F., Knowles, R. G., East, N., Balkwill, F. R. (1995) The role of indoleamine 2,3-dioxygenase in the anti-tumor activity of human interferon-γ in vivo. Int. J. Cancer 60, 115-122.
39. Terness, P., Bauer, T. M., Rose, L., Dufter, C., Watzlik, A., Simon, H., Opelz, G. (2002) Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196, 447-457.
40. Frumento, G., Rotondo, R., Tonetti, M., Damonte, G., Benatti, U., Ferrara, G. B. (2002) Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med. 196, 459-468.
41. Kudo, Y., Boyd, C. A., Sargent, I. L., Redman, C. W. (2001) Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation. J. Physiol. 535, 207-215.
42. Travers, M. T., Gow, I. F., Barber, M. C., Thomson, J., Shennan, D. B. (2004) Indoleamine 2,3-dioxygenase activity and L-tryptophan transport in human breast cancer cells. Biochim. Biophys. Acta 1661, 106-112.